Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	8.4	9.87	1.63	14.17	24.42	6.21
Research & Development	7.4	8.11	12.96	13.21	5.99	3.71
Operating Expenses	15.8	17.98	14.59	27.37	30.41	9.92
Operating Income	-15.8	-17.98	-14.59	-27.37	-30.41	-9.92
Interest Expense	-0.01	-0.01	-0.01	-0.18	-0.32	-0.09
Interest & Investment Income	1.27	1.15	0.03	-	0.01	0
Other Non Operating Income (Expenses)	-	-	0.03	0.89	-	-
EBT Excluding Unusual Items	-14.54	-16.84	-14.53	-26.66	-30.72	-10.01
Gain (Loss) on Sale of Investments	-2.07	-0.4	-0.87	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	2.66	-
Asset Writedown	-	-	-	-	-0.28	-
Pretax Income	-16.61	-17.24	-15.4	-26.66	-28.34	-10.01
Income Tax Expense	-2.88	0.45	-	-3.24	-2.21	-0.69
Net Income	-13.73	-17.69	-15.4	-23.42	-26.13	-9.32
Net Income to Common	-13.73	-17.69	-15.4	-23.42	-26.13	-9.32
Shares Outstanding (Basic)	103	102	102	98	97	97
Shares Outstanding (Diluted)	103	102	102	98	97	97
Shares Change (YoY)	-0.78%	0.93%	3.67%	0.64%	-	-23.71%
EPS (Basic)	-0.13	-0.17	-0.15	-0.24	-0.27	-0.10
EPS (Diluted)	-0.13	-0.17	-0.15	-0.24	-0.27	-0.10
Free Cash Flow	-3.92	-15.7	-19.62	-21.78	-11.34	-6.8
Free Cash Flow Per Share	-0.04	-0.15	-0.19	-0.22	-0.12	-0.07
EBITDA	-15.79	-17.98	-14.59	-27.37	-30.41	-9.92
D&A For EBITDA	0.01	0.01	0	0.01	0.01	0.01
EBIT	-15.8	-17.98	-14.59	-27.37	-30.41	-9.92

Updated Oct 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q